Ann: Medicinal Cannabis Product Licensing Applications, page-44

Numerous positive sides of IHL :

1. Once licences granted, Impression will become one of Australia’s first licensed distributors of medicinal     cannabis products,

2. Have the ability to import, store, distribute and export medicinal cannabis products from its laboratory and manufacturing facility in Melbourne, Australia.

3. US Collaboration -  already struck a deal with US-based cannabis supplier AXIM Biotechnologies, a company that has developed a plethora of cannabis-derived products.

AXIM is a leading cannabinoid biotech company that develops and manufactures products for a wide variety of intended purposes including the world’s first patented CBD-infused chewing gum with various strengths for the treatment of a range of indications, including pain related to Multiple Sclerosis.

https://*********.com.au/impression-healthcare-prepares-medical-cannabis-market-launch/